UNSPSC 51333501: Clopimozide

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51333501

Definition

This classification denotes a dopamine antagonist with the molecular formula C28H28ClF2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C6TA32SD2, chemically known as 5-chloro-1-(4-(4,4-bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone but generally known as clopimozide, which bears US NIH Compound Identifier 65449. European Medicines Agency schedules Clopimozide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06740MIG.

Read the full definition

The term CLOPIMOZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). CLOPIMOZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clopimozide under HS 29333999 and SITC 51574. As of Q4 2014, CLOPIMOZIDE remains the US FDA Preferred Term for this commodity. Clopimozide bears US NLM identifiers UMLS ID C0055934 and NCI Concept Code C77571. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CCCC(C3CCC(F)CC3)C3CCC(F)CC3)C2CC1.

About UNSPSC 51333501

UNSPSC 51333501 Clopimozide is a Commodity code that captures pharmaceutical procurement for opioid-antagonist and drug-deactivation products used by state and local health and emergency-response agencies. The recent solicitation record shows state and local governments buying naloxone and safe drug-deactivation systems — products aligned with community health and opioid-mitigation initiatives rather than clopimozide specifically. The code appears to span pharmaceutical products used in overdose response and harm-reduction programs, with issuing bodies including county health departments and community health agencies pursuing competitive procurement through IFB notice types.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The bid deadline was July 26, 2023, with fixed-fee pricing and a two-year initial term plus one-year renewal option. Vendors must provide unit costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation and commercial general liability insurance. The procurement potentially carries FEMA funding and attendant federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act, with a three-month probationary period allowing termination by the county without cause. The recent-opportunities record shows limited activity under this code; the sole recent example is from Seminole County, Florida, suggesting that state and local purchasing under this Commodity code remains concentrated in Florida and driven by county-level health departments.

Quick answers

What is UNSPSC 51333501?

UNSPSC 51333501 is Clopimozide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51333501?

UNSPSC 51333501 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51333501

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code